PetMed Express Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
PetMed Express, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Revenue & Gross Profit
Revenue226.97274.10247.57272.28309.22284.13283.42
Cost of Revenue157.84189.33171.07195.34219.27202.88188.11
Gross Profit69.1484.7776.5076.9489.9581.2595.31
Operating Expenses
Research & Development0.000.000.000.000.000.000.00
Selling, General & Administrative62.4385.8765.7049.9149.9348.0146.92
Operating Expenses70.6792.9369.5952.6552.3650.2749.14
Operating Income-1.53-8.166.9224.2937.5930.9846.17
Other Income/Expense
Interest Income0.000.510.450.340.000.001.86
Interest Expense0.000.000.00-1.13-0.900.000.00
Other Income/Expense0.941.380.941.03-1.32-1.171.08
Income
Income Before Tax-0.59-6.277.4524.1939.2233.8949.12
Income Tax Expense5.681.192.315.478.618.0411.38
Net Income-6.27-7.465.1418.7230.6025.8537.74
Net Income - Continuous Operations-6.27-7.465.1418.720.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA6.71-1.1110.4627.0340.0136.1548.40
EBIT-8.29-8.166.9224.2937.5933.8946.17
Depreciation & Amortization7.047.063.552.742.432.262.23
Earnings Per Share
Basic EPS---1.002.001.002.00
Diluted EPS---1.002.001.002.00
Basic Shares Outstanding20.6020.4020.2720.1820.0620.0420.46
Diluted Shares Outstanding20.6020.4020.3420.3620.1220.0620.49